Chief Medical Officer, England
Dame Sally became Chief Medical Officer for England in March 2011. She is the most senior independent advisor to the UK Government on medical matters, with particular responsibilities regarding public and global health. She was previously the Chief Scientific Adviser for the Department of Health from 2004, where she founded the National institute for Health Research.
Dame Sally sits on the World Health Organization (WHO) Executive Board. She advises many governments on health and policy, holding positions on a number of boards and groups, including the Singapore A Star international Advisory Group and University of Washington institute for Health Metrics and Evaluation Board.
In 2013 Dame Sally published a report on infectious diseases bringing renewed focus on the increasing threat of antimicrobial resistance (AMR), and calling for action to address the key areas of: stewardship; monitoring and surveillance; and antibiotic development. Since this publication, Dame Sally continues to advocate globally on AMR, including a recent high-level meeting at the United Nations General Assembly. She was chairperson of the 2013 WISH AMR forum and is chair of the Strategic and Technical Advisory Group on AMR to the WHO.
In 2014 Dame Sally was elected Fellow of the Royal Society and in 2015 a member of the National Academy of Medicine in the US.
President, University of Miami
Dr Julio Frenk became President of the University of Miami in 2015, where he is also Professor of both Public Health Sciences and Health Sector Management and Policy.
Prior to joining the University of Miami, Dr Frenk was Dean of the Faculty at the Harvard TH Chan School of Public Health and also the T & G Angelopoulos Professor of Public Health and international Development. He served as Minister of Health in Mexico from 2000 to 2006, where he pursued ambitious health system reforms and introduced a program of universal coverage, which expanded access to healthcare for over 55 million previously uninsured Mexicans. Dr Frenk was founding Director- General of the National institute of Public Health in Mexico. in 1998, he joined the World Health Organization as Executive Director in charge of Evidence and information for Policy, explicitly charged with developing a scientific foundation for health policy to achieve better outcomes.
He also served as a Senior Fellow in the Global Health Program of the Bill & Melinda Gates Foundation and as President of the Carso Health institute in Mexico City. He is the founding Chairman of the board of the institute for Health Metrics and Evaluation at the University of Washington.
Dr Frenk holds a medical degree from the National University of Mexico, and a Master of Public Health and a joint PhD in Medical Care Organization and Sociology from the University of Michigan. He received the Clinton Global Citizen Award in 2008.
Charles W Eliot University Professor and President Emeritus, Harvard University
Dr Summers is President Emeritus and Charles W Eliot University Professor at Harvard University. He directs the University’s Mossavar- Rahmani Center for Business and Government. Dr Summers has served as Secretary of the Treasury and as Director of the White House National Economic Council, President of Harvard University, and as the Chief Economist of the World Bank.
As President of Harvard he focused on equality of opportunity and removing financial obligation from students with low incomes. He aimed to make Boston the global leader in life sciences research with the formation of programs for stem cell research and genomics.
Dr Summers was the first social scientist to receive the National Science Foundation’s Alan Waterman Award for scientific achievement and, in 1993, he was awarded the John Bates Clark Medal. He was elected to the National Academy of Sciences in 2002.
Dr Summers is an advisor to businesses and investors. He chairs the boards of Citizen Schools and the Center for Global Development. He serves on the board of Teach for America and campaigning and advocacy organization ONE. He is an advisor to The Hamilton Project, The Hutchins Center on Fiscal and Monetary Policy and the Peterson institute for international Economics. He is a distinguished Senior Fellow at the Center for American Progress, chaired the Commission on Global Health and co-chaired the Commission on inclusive Prosperity.
Mustafa Suleyman is co-founder and Head of Applied Artificial intelligence at DeepMind, where he is responsible for integrating the company’s technology across a wide range of Google products. in February 2016 he launched DeepMind Health, which builds clinician-led technology in the UK National Health Service. Mustafa was Chief Product Officer at DeepMind Technologies, before the company was bought in 2014 by Google in their largest European acquisition to date.
At 19, Mustafa dropped out of the University of Oxford to help set up a telephone counseling service, building it to become one of the largest mental health support services of its kind in the UK, and then worked as policy officer for then Mayor of London, Ken Livingstone. He went on to help start Reos Partners, a consultancy with eight offices across four continents specializing in designing and facilitating large-scale multi-stakeholder ‘Change Labs’, aimed at navigating complex problems. As a skilled negotiator and facilitator Mustafa has worked all over the world for a wide range of clients such as the UN, the Government of the Netherlands and the World Wide Fund for Nature (WWF).